KEYVANTAGE WEALTH, LLC

Position in LLY — ELI LILLY & Co

CIK 2050555 BETHLEHEM, PA

Position in LLY

as of Jun 30, 2026 · filed Aug 11, 2026 Compact

Position Value

$712,461

+$141,284 QoQ

Shares Held

594

-4.3% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

1.23%

of 13F equity value

Holder Rank

#3,437

of 4,605 holders

Holding Since

Dec 2024

7 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

KEYVANTAGE WEALTH, LLC holds $3,559,634 across 5 Drug Manufacturers - General names. LLY ranks #2 (20.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	JNJ	Johnson & Johnson	4,167	$1,058,292
2	LLY	ELI LILLY & Co This page	594	$712,461
3	GILD	Gilead Sciences, Inc.	5,453	$688,932
4	MRK	Merck & Co., Inc.	4,857	$624,124
5	AMGN	Amgen Inc	1,314	$475,825

7 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$712,461	594	-4.3%	Shares	Sole	2026-08-11
2026-03-31	$571,177	621	+0.8%	Shares	Sole	2026-05-05
2025-12-31	$662,002	616	+80.1%	Shares	Sole	2026-02-10
2025-09-30	$260,946	342	-36.3%	Shares	Sole	2025-11-07
2025-06-30	$418,607	537	-13.2%	Shares	Sole	2025-08-08
2025-03-31	$511,238	619	-50.6%	Shares	Sole	2025-05-07
2024-12-31	$967,316	1,253	—	Shares	Sole	2025-02-14
No filing history on record for this holder in this stock.